Pascal Artru - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Pascal Artru

Showing results (41-50 of 83) with videos related to

Pageof 9

Sort By:

Clinical Colorectal Cancer|March 26, 2022

Sequential Treatment With Trifluridine/Tipiracil and Regorafenib in Refractory Metastatic Colorectal Cancer Patients: An AGEO Prospective "Real-World Study"Clélia Coutzac, Isabelle Trouilloud, Pascal Artru, et al.

Clinics and Research in Hepatology and Gastroenterology|October 15, 2019

Three fluoropyrimidine-based regimens in routine clinical practice after nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: An AGEO multicenter studyAnne-Laure Pointet, David Tougeron, Simon Pernot, et al.

British Journal of Cancer|June 9, 2020

Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 studySimon Pernot, Olivier Pellerin, Pascal Artru, et al.

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 14, 2016

Perioperative chemotherapy with FOLFOX in resectable gastroesophageal adenocarcinoma in real life practice: An AGEO multicenter retrospective studyFlorence Mary, Aziz Zaanan, Valérie Boige, et al.

European Journal of Cancer (Oxford, England : 1990)|December 19, 2022

Comparison of short course radiotherapy with chemoradiotherapy for locally advanced rectal cancers in the elderly: A multicentre, randomised, non-blinded, phase 3 trialEric François, Berardino De Bari, Philippe Ronchin, et al.

European Journal of Cancer (Oxford, England : 1990)|February 5, 2016

Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOXGérard Lledo, Florence Huguet, Benoist Chibaudel, et al.

British Journal of Cancer|July 13, 2016

Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)Dewi Vernerey, Florence Huguet, Angélique Vienot, et al.

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 2, 2021

First-line chemotherapy with raltitrexed in metastatic colorectal cancer: an Association des Gastro-entérologues Oncologues (AGEO) multicentre studyClaire Gallois, Emilie Hafliger, Edouard Auclin, et al.

JAMA Oncology|November 14, 2018

Continuation of Bevacizumab vs Cetuximab Plus Chemotherapy After First Progression in KRAS Wild-Type Metastatic Colorectal Cancer: The UNICANCER PRODIGE18 Randomized Clinical TrialJaafar Bennouna, Sandrine Hiret, Aurelie Bertaut, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2009

Can chemotherapy be discontinued in unresectable metastatic colorectal cancer? The GERCOR OPTIMOX2 StudyBenoist Chibaudel, Frédérique Maindrault-Goebel, Gérard Lledo, et al.

Pageof 9

Search research articles

Showing results (41-50 of 83) with videos related to

Sort By:

Pageof 9

Clinical Colorectal Cancer|March 26, 2022

Clinics and Research in Hepatology and Gastroenterology|October 15, 2019

British Journal of Cancer|June 9, 2020

Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 studySimon Pernot, Olivier Pellerin, Pascal Artru, et al.

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 14, 2016

Perioperative chemotherapy with FOLFOX in resectable gastroesophageal adenocarcinoma in real life practice: An AGEO multicenter retrospective studyFlorence Mary, Aziz Zaanan, Valérie Boige, et al.

European Journal of Cancer (Oxford, England : 1990)|December 19, 2022

European Journal of Cancer (Oxford, England : 1990)|February 5, 2016

Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOXGérard Lledo, Florence Huguet, Benoist Chibaudel, et al.

British Journal of Cancer|July 13, 2016

Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)Dewi Vernerey, Florence Huguet, Angélique Vienot, et al.

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 2, 2021

JAMA Oncology|November 14, 2018

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2009

Can chemotherapy be discontinued in unresectable metastatic colorectal cancer? The GERCOR OPTIMOX2 StudyBenoist Chibaudel, Frédérique Maindrault-Goebel, Gérard Lledo, et al.

Pageof 9